Your food and beverage industry news from the United States
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
8 hours ago
Sushiro to Open First U.S. Store in New York
As featured in:
@ Journalists!
Join
Press releases
Publish your press release
May. 10, 2026
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
GlobeNewswire, Inc.
MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the label strategy for sonelokimab (SLK) in...
12 hours ago
Bringing your pet to Okinawa: What to expect and who’s here to help
DVIDS - Georgia
TORII STATION, Japan – For military families, moving overseas often means navigating tight timelines, new languages and unfamiliar processes.
May. 8, 2026
Creating Jobs in Philadelphia: Governor Shapiro Secures $3.8 Million Investment from Bonduelle Americas to Open its New U.S. Growth Hub in Pennsylvania, Creating Over 100 Jobs
Pennsylvania Department of Community & Economic Development
The Commonwealth is investing $500,000 to support the food manufacturer’s new U.S. Growth Hub in the City of Philadelphia.
May. 8, 2026
Creating Jobs in Philadelphia: Governor Shapiro Secures $3.8 Million Investment from Bonduelle Americas to Open its New U.S. Growth Hub in Pennsylvania, Creating Over 100 Jobs
Pennsylvania Department of Community & Economic Development
The Commonwealth is investing $500,000 to support the food manufacturer’s new U.S. Growth Hub in the City of Philadelphia.
May. 8, 2026
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
GlobeNewswire, Inc.
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that a...
May. 8, 2026
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
GlobeNewswire, Inc.
VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab positive, anti-MuSK-Ab positive, anti-LRP4-Ab positive, and triple seronegative Patients treated with VYVGART...
Video Stories
Discover Affinity Group Publishing
Sign up for:
American Food & Beverage Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
